ArticleArthritis research & therapy2005
Clinical and laboratory characteristics of drug-induced vasculitic syndromes.
Article in Arthritis research & therapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 45 citations in OpenAlex.
- Propylthiouracil-induced vasculitis with alveolar hemorrhage after 31 years of treatment: a case report.Clinical diabetes and endocrinology · 2024Article
- Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious PubertyJournal of clinical research in pediatric endocrinology · 2023Article
- Doxycycline-Induced Antinuclear Antibody and Antineutrophil Cytoplasmic Antibody Associated Vasculitis: A Case Report and Literature Review.Case reports in rheumatology · 2020Article
- Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.Chinese medical journal · 2019Review
- Drug-induced glomerular disease: attention required!Clinical journal of the American Society of Nephrology : CJASN · 2015Review
- Drug-induced glomerular disease: immune-mediated injury.Clinical journal of the American Society of Nephrology : CJASN · 2015Review
- The immunopathology of ANCA-associated vasculitis.Seminars in immunopathology · 2014Review
- Bilateral renal ischemia after kyphoplasty and clodronate treatment: a case report.Journal of medical case reports · 2014Article
- Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.Nature reviews. Nephrology · 2012Review
- The "other" vasculitis syndromes and kidney involvement.Pediatric nephrology (Berlin, Germany) · 2010Review
- Infection and vasculitis.Rheumatology (Oxford, England) · 2009Review
- Necrotizing vasculitis as a complication of propylthiouracil.The western journal of emergency medicine · 2008Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase-antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.